Atlas Trials

Buspirone Hydrochloride 30mg Tablets, Fasting

Clinical trial NCT00840606 · COMPLETED

Trial details

NCT number
NCT00840606
Sponsor
Teva Pharmaceuticals USA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2001-12-01
Primary completion
2001-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.